Hi Maya. I read your CLAUDE.md and all three files in ./evidence (funnel_weekly.csv, tickets.txt, release_notes.txt) before doing anything else.

**Before I start, here is what I understand. Gate score: 95 (lowest: the goal and my role, both 95).**

- Your ask: a one-page brief for Dana on whether to roll back the 3 Oct pricing page, based on why trial-to-paid dropped. I am not building a prototype, PRD or deck.
- Who you are: PM for Checkout, reporting to Dana Ortiz (VP Product). You know the funnel; you are not an analyst, so every number comes with its rows and the writing stays plain. You read first, then Dana.
- What you're trying to achieve: Dana decides at Monday's review (I assume Mon 12 Oct) after you hand in the brief Fri 9 Oct. Good = a recommendation she can act on, with how sure we are and what would change it.
- My role: I read, analyze and draft, writing only into the outputs folder. I check with you before anything is emailed, posted, committed or pushed. I won't name a cause the data does not support, and I label guesses.

Assumptions: "Monday" is 12 Oct, and mentioning a partial fix as an option is fine alongside a roll back / keep recommendation. Tell me if either is wrong. Otherwise I'm continuing.

**What I did (phases 1 and 2, onboarding and evidence map)**

Files in the outputs folder: charter.md, working-context.md, evidence-map.md.

**First look** (rows, not a cause):

| Week starting | All | Annual | Monthly |
|---|---|---|---|
| 7 Sep | 0.31 | 0.36 | 0.27 |
| 14 Sep | 0.30 | 0.35 | 0.27 |
| 21 Sep | 0.31 | 0.36 | 0.27 |
| 28 Sep | 0.30 | 0.35 | 0.27 |
| 5 Oct | 0.22 | 0.20 | 0.23 |

- The drop is not even. Annual fell about 15 points; monthly about 4. The all-plans number hides that annual carries most of it.
- Pricing page views (about 2,250) and trial starts (about 530 a week) did not move. What changed is the share who convert.
- 4 of the 5 tickets (6-8 Oct) are about price or discount or the checkout, 3 of them about annual plans. For example, T-102: "Where did the annual discount go? It used to say 'save 20%'." Five tickets cannot tell us scale. The release notes mention the annual badge moving into checkout, which is a place to look, not a finding.

**Things that could bend the numbers**
- Your notes say Fri 3 Oct, but 3 Oct 2026 is a Saturday. One of the two is off. The weeks in the data start on Mondays, so 3 Oct falls in the 28 Sep week, which shows no drop.
- The 5 Oct week is only a few days old. If trials need time to convert, that row may be partly unfinished, which would lower the rate by itself. I can't tell from the file how trial_to_paid is calculated.
- Several tickets describe wrong prices or the wrong plan being charged (T-101, T-105). That could be a bug rather than a design problem, and the release notes don't cover it.

**Three questions, most important first** (a plain "yes" is fine where I gave a guess):
1. How is trial_to_paid calculated, and is the 5 Oct row complete? (My guess: share of trials started that week who have paid so far, so the latest week is partial. Who in analytics can confirm, and can they send daily numbers by plan from 28 Sep?)
2. Did anything else change from about 1 Oct (a campaign, billing or checkout code, a price)? (My guess: no, but I only have the one release note.)
3. Is the 3 Oct date right, with the weekday wrong, or was it really Friday 2 Oct? (My guess: 3 Oct is right and "Fri" is a slip.)

I'm stopping here until you answer. I have not contacted anyone, and I haven't drafted a conclusion; the next step is counting the tickets and checking the split by plan more closely, then hypotheses, so the brief reflects what the data supports. If question 1 can't be answered by Friday, the brief will say plainly that the latest week may be incomplete.
